CIBC Cuts DRI Healthcare Trust (TSE:DHT.UN) Price Target to C$18.00

DRI Healthcare Trust (TSE:DHT.UN) had its target price trimmed by CIBC from C$19.50 to C$18.00 in a research note published on Thursday morning,BayStreet.CA reports. The firm currently has an outperform rating on the stock.

A number of other equities analysts also recently commented on the stock. Scotiabank raised their price objective on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Raymond James decreased their price target on DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of C$17.94.

DRI Healthcare Trust Trading Down 0.5 %

Shares of TSE:DHT.UN opened at C$12.16 on Thursday. The business has a fifty day simple moving average of C$13.35 and a 200 day simple moving average of C$13.21. DRI Healthcare Trust has a 1 year low of C$10.39 and a 1 year high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were paid a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date was Friday, September 27th. DRI Healthcare Trust’s dividend payout ratio (DPR) is presently -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.